- conflicts or gaps
- [[{"field": "founded_year", "conflict": "Sources report 2017 (CB Insights, Pitch.vc, Tracxn) vs 2018 (Crunchbase).", "source_urls": ["https://www.cbinsights.com/company/excepgen", "https://www.crunchbase.com/organization/excepgen", "https://pitch.vc/companies/excepgen"]}, {"field": "total_funding_usd", "conflict": "Company press release and secondary coverage report $14M total seed; CB Insights reports $4.15M total raised.", "source_urls": ["https://www.prnewswire.com/news-releases/excepgen-emerges-from-stealth-with-new-funding-for-its-nucleic-acid-therapeutics-platform-301908792.html", "https://www.cbinsights.com/company/excepgen"]}, {"field": "latest_round_stage", "conflict": "Aug 2023 round labeled Seed by company PR and Crunchbase; Tracxn labels it Series A.", "source_urls": ["https://www.prnewswire.com/news-releases/excepgen-emerges-from-stealth-with-new-funding-for-its-nucleic-acid-therapeutics-platform-301908792.html", "https://www.crunchbase.com/organization/excepgen", "https://tracxn.com/d/companies/excepgen/__fVW7zd-UilC_Qqm2OLNV7iQbrqYWXHJl3EgsFiYhWZk"]}, {"field": "headquarters_location", "conflict": "YC and company site list San Francisco; YCDB lists London, England.", "source_urls": ["https://www.ycombinator.com/companies/excepgen", "http://www.ycdb.co/company/excepgen", "https://www.excepgen.com/team"]}, {"field": "headquarters_address", "conflict": "Company website lists 780 Bryant St, San Francisco; 2025 publication lists ExcepGen Inc. affiliation as Emeryville, San Francisco, CA.", "source_urls": ["https://www.excepgen.com/team", "https://pmc.ncbi.nlm.nih.gov/articles/PMC12041602/"]}, {"field": "employee_count", "conflict": "YC still reports team_size 3; company team page lists 6 named members and open roles; Crunchbase reports 1-10.", "source_urls": ["https://yc-oss.github.io/api/batches/winter-2019/excepgen.json", "https://www.excepgen.com/team", "https://www.crunchbase.com/organization/excepgen"]}, {"field": "yc_founders_list", "conflict": "YC company page lists Thomas Folliard twice and omits co-founder Barbara Mertins.", "source_urls": ["https://www.ycombinator.com/companies/excepgen", "https://www.excepgen.com/team", "https://www.prnewswire.com/news-releases/excepgen-emerges-from-stealth-with-new-funding-for-its-nucleic-acid-therapeutics-platform-301908792.html"]}, {"field": "product_focus", "conflict": "2019 launch centered on protein expression for pharma discovery; current public positioning pivoted to nucleic acid therapeutics / RNAx mRNA platform (stealth re-emergence Aug 2023).", "source_urls": ["https://www.fiercebiotech.com/biotech/excepgen-emerges-from-y-combinator-taking-aim-at-better-proteins-for-drug-discovery", "https://www.excepgen.com/", "https://www.prnewswire.com/news-releases/excepgen-emerges-from-stealth-with-new-funding-for-its-nucleic-acid-therapeutics-platform-301908792.html"]}, {"field": "first_seed_round_amount", "conflict": "Mar 2019 seed round date reported by Tracxn; round amount not publicly disclosed.", "source_urls": ["https://tracxn.com/d/companies/excepgen/__fVW7zd-UilC_Qqm2OLNV7iQbrqYWXHJl3EgsFiYhWZk"]}, {"field": "yc_one_liner", "conflict": "YC OSS API and YC page show empty one_liner and long_description.", "source_urls": ["https://yc-oss.github.io/api/batches/winter-2019/excepgen.json", "https://www.ycombinator.com/companies/excepgen"]}, {"field": "additional_pharma_partners_2019", "conflict": "Fierce Biotech reported three Big Pharma partnerships at launch but named only AstraZeneca.", "source_urls": ["https://www.fiercebiotech.com/biotech/excepgen-emerges-from-y-combinator-taking-aim-at-better-proteins-for-drug-discovery"]}]]
- source urls
- ["http://www.ycdb.co/company/excepgen", "https://longevity.technology/news/excepgen-emerges-from-stealth-targets-genetic-medicine-revolution/", "https://pitch.vc/companies/excepgen", "https://pmc.ncbi.nlm.nih.gov/articles/PMC12041602/", "https://tracxn.com/d/companies/excepgen/__fVW7zd-UilC_Qqm2OLNV7iQbrqYWXHJl3EgsFiYhWZk", "https://www.cbinsights.com/company/excepgen", "https://www.crunchbase.com/organization/excepgen", "https://www.excepgen.com/", "https://www.excepgen.com/team", "https://www.fiercebiotech.com/biotech/excepgen-emerges-from-y-combinator-taking-aim-at-better-proteins-for-drug-discovery", "https://www.prnewswire.com/news-releases/excepgen-emerges-from-stealth-with-new-funding-for-its-nucleic-acid-therapeutics-platform-301908792.html", "https://www.ycombinator.com/companies/excepgen", "https://www.ycombinator.com/companies/industry/therapeutics", "https://yc-oss.github.io/api/batches/winter-2019/excepgen.json"]